DERM logo

Journey Medical Corporation (DERM)

Profile

Full Name

Journey Medical Corporation

Ticker

NASDAQ: DERM

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

November 12, 2021

Indexes

Not included

Website

http://journeymedicalcorp.com

Employees

41

Key Details

Price

$7.22(+1.12%)

Market cap

$168.20M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$56.13M(-29.11% YoY)

Annual EPS

-$0.72(-242.86% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.22
    DERM price is $7.22

    30-Day Relative Volume

    0.47
    DERM 30-day relative volume is 0.47

    Price Performance

    Price Most recent change

    +1.12%
    DERM price was up +1.12% on Jul 10, 2025

    Price YTD change

    +84.65%
    DERM price is up +84.65% since January 1st

    Price 1-year change

    +31.03%
    DERM price is up +31.03% year-on-year

    Price 3-year change

    +106.88%
    DERM price is up +106.88% over the past 3 years

    Price Range

    Price All-time high

    $10.20
    DERM price is currently -29.22% below its historical high of $10.20

    Price 3-year low

    $1.02
    DERM price is currently +607.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $168.20M
    DERM market capitalization is $168.20 million

    Market cap 3-year change

    +174.51%
    DERM market capitalization is up +174.51% over the past 3 years

    Market cap All-time high

    $188.00M
    DERM market capitalization is currently -10.53% below its historical high of $188.00 million

    Market cap sector rank

    50.41%
    DERM market capitalization is higher than 50.41% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +16.37%
    DERM shares outstanding is up +16.37% year-on-year

    Shares Outstanding 3-Year Change

    +32.69%
    DERM shares outstanding is up +32.69% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.82
    DERM beta is 0.82

    200-day SMA

    $5.80
    DERM price is currently +24.45% above its 200-day simple moving average

    50-day SMA

    $7.03
    DERM price is currently +2.66% above its 50-day simple moving average

    RSI

    54.99
    DERM 14-day relative strength index is 54.99

    Volume

    0.47
    DERM 30-day relative volume is 0.47

    ATR

    $0.37
    DERM average true range is $0.37

    10-day Historical Volatility

    29.89%
    DERM 10-day historical volatility is 29.89%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $56.13M
    DERM annual revenue is $56.13 million

    Revenue Analysts estimate

    $70.99M
    DERM annual revenue is currently -20.92% lower than the consensus analysts' forecast

    Revenue 1-year change

    -29.11%
    DERM annual revenue is down -29.11% year-on-year

    Revenue Sector rank

    48.22%
    DERM annual revenue is higher than 48.22% of companies in Healthcare sector

    EPS

    EPS

    -$0.72
    DERM annual earnings per share is -$0.72

    EPS Analysts estimate

    -
    DERM annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -242.86%
    DERM annual earnings per share is down -242.86% year-on-year

    EPS Sector rank

    62.96%
    DERM annual earnings per share is higher than 62.96% of companies in Healthcare sector

    Profit

    Gross profit

    $35.26M
    DERM annual gross profit is $35.26 million

    Gross margin

    62.81%
    DERM annual gross profit margin is 62.81%

    Operating profit

    -$18.23M
    DERM annual operating income is -$18.23 million

    Operating margin

    -32.48%
    DERM annual operating profit margin is -32.48%

    Net income

    -$14.67M
    DERM annual net profit is -$14.67 million

    Net margin

    -26.14%
    DERM annual net profit margin is -26.14%

    Expenses

    Total expenses

    $74.36M
    DERM annual total expenses is $74.36 million

    Operating expenses

    $53.48M
    DERM annual total operating expenses is $53.48 million

    Cost of goods sold

    $20.88M
    DERM annual cost of goods sold is $20.88 million

    Selling, general & administrative expenses

    $40.20M
    DERM annual SGA is $40.20 million

    Depreciation and amortization

    $3.52M
    DERM annual depreciation & amortization is $3.52 million

    Interest expense

    $2.70M
    DERM annual interest expense is $2.70 million

    Income tax

    $61.00K
    DERM annual income tax is $61.00 thousand

    EBIT & EBITDA

    EBIT

    -$11.91M
    DERM annual earnings before interest & taxes is -$11.91 million

    EBITDA

    -$8.40M
    DERM annual EBITDA is -$8.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $80.24M
    DERM annual total assets is $80.24 million

    Non current assets

    $32.06M
    DERM annual long term assets is $32.06 million

    Current assets

    $48.18M
    DERM annual total current assets is $48.18 million

    Cash and cash equivalents

    $20.30M
    DERM annual cash & cash equivalents is $20.30 million

    Accounts receivable

    $10.23M
    DERM annual accounts receivable is $10.23 million

    Inventory

    $14.43M
    DERM annual inventory is $14.43 million

    Liabilities

    Total liabilities

    $60.17M
    DERM annual total liabilities is $60.17 million

    Long term liabilities

    $25.00M
    DERM annual total long term liabilities is $25.00 million

    Current liabilities

    $35.17M
    DERM annual total current liabilities is $35.17 million

    Accounts payable

    $16.05M
    DERM annual accounts payable is $16.05 million

    Debt

    Total debt

    $25.08M
    DERM annual total debt is $25.08 million

    Total debt 1-year change

    +70.26%
    DERM annual total debt is up +70.26% year-on-year

    Long term debt

    $25.00M
    DERM annual long term debt is $25.00 million

    Short term debt

    $83.00K
    DERM annual short term debt is $83.00 thousand

    Equity & Capital

    Shareholders equity

    $20.07M
    DERM annual stockholders equity is $20.07 million

    Book value

    $20.07M
    DERM annual book value is $20.07 million

    Retained earnings

    -$87.03M
    DERM annual retained earnings is -$87.03 million

    Working capital

    $13.00M
    DERM annual working capital is $13.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.13M
    DERM annual cash flow from operations is -$9.13 million

    Cash from operations 1-year change

    -274.18%
    DERM annual cash flow from operations is down -274.18% year-on-year

    Cash from investing

    -$15.00M
    DERM annual cash flow from investing activities is -$15.00 million

    Cash from investing 1-year change

    -200%
    DERM annual cash flow from investing activities is down -200% year-on-year

    Cash from financing

    $16.99M
    DERM annual cash flow from financing activities is $16.99 million

    Cash from financing 1-year change

    +453.73%
    DERM annual cash flow from financing activities is up +453.73% year-on-year

    CAPEX

    CAPEX

    $15.00M
    DERM annual capital expenditures is $15.00 million

    CAPEX 1-year change

    +200%
    DERM annual capital expenditures is up +200% year-on-year

    Free Cash Flow

    Free cash flow

    -$24.13M
    DERM annual free cash flow is -$24.13 million

    Free cash flow 1-year change

    -10152.92%
    DERM annual free cash flow is down -10152.92% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    62.81%
    DERM annual gross profit margin is 62.81%

    Operating margin

    -32.48%
    DERM annual operating profit margin is -32.48%

    Net margin

    -26.14%
    DERM annual net profit margin is -26.14%

    ROA & ROE

    ROA

    -18.68%
    DERM annual return on assets is -18.68%

    ROE

    -72.60%
    DERM annual return on equity is -72.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DERM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DERM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    7.81
    DERM price to book ratio is 7.81

    PB ratio Sector rank

    86.52%
    DERM price to book ratio is higher than 86.52% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.99
    DERM price to sales ratio is 2.99

    PS ratio Sector rank

    49.73%
    DERM price to sales ratio is higher than 49.73% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $172.29M
    DERM enterprise value is $172.29 million

    Enterprise value Sector rank

    52%
    DERM enterprise value is higher than 52% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -120.15
    DERM EV/EBITDA is -120.15

    EV/EBITDA Sector rank

    1.76%
    DERM EV/EBITDA is higher than 1.76% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.37
    DERM annual current ratio is 1.37

    Quick ratio

    0.96
    DERM annual quick ratio is 0.96

    Leverage

    Debt to equity

    1.24
    DERM annual debt to equity ratio is 1.24

    Interest coverage ratio

    -4.41
    DERM annual interest coverage ratio is -4.41

    Risk & Stability

    Piotroski F-Score

    3
    DERM piotroski f-score is 3

    Altman Z-Score

    0.56
    DERM altman z-score is 0.56

    Analyst ratings

    Recent major analysts updates

    Feb 16, 24 Alliance Global Partners
    Buy
    Sep 7, 23 B. Riley Securities
    Buy
    Jul 12, 23 B. Riley Securities
    Buy
    May 23, 23 B. Riley Securities
    Buy
    Mar 30, 23 B. Riley Securities
    Buy
    Feb 25, 22 Cantor Fitzgerald
    Overweight
    Dec 16, 21 Roth Capital
    Buy
    Dec 7, 21 B. Riley Securities
    Buy

    Institutional Ownership

    Screeners with DERM included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    Best performing stocks last 3 years
    • What is the ticker symbol for Journey Medical Corporation?
    • Does Journey Medical Corporation pay dividends?
    • What sector is Journey Medical Corporation in?
    • What industry is Journey Medical Corporation in?
    • What country is Journey Medical Corporation based in?
    • When did Journey Medical Corporation go public?
    • Is Journey Medical Corporation in the S&P 500?
    • Is Journey Medical Corporation in the NASDAQ 100?
    • Is Journey Medical Corporation in the Dow Jones?
    • When was Journey Medical Corporation's last earnings report?
    • When does Journey Medical Corporation report earnings?

    What is the ticker symbol for Journey Medical Corporation?

    The ticker symbol for Journey Medical Corporation is NASDAQ:DERM

    Does Journey Medical Corporation pay dividends?

    No, Journey Medical Corporation does not pay dividends

    What sector is Journey Medical Corporation in?

    Journey Medical Corporation is in the Healthcare sector

    What industry is Journey Medical Corporation in?

    Journey Medical Corporation is in the Drug Manufacturers - Specialty & Generic industry

    What country is Journey Medical Corporation based in?

    Journey Medical Corporation is headquartered in United States

    When did Journey Medical Corporation go public?

    Journey Medical Corporation's initial public offering (IPO) was on November 12, 2021

    Is Journey Medical Corporation in the S&P 500?

    No, Journey Medical Corporation is not included in the S&P 500 index

    Is Journey Medical Corporation in the NASDAQ 100?

    No, Journey Medical Corporation is not included in the NASDAQ 100 index

    Is Journey Medical Corporation in the Dow Jones?

    No, Journey Medical Corporation is not included in the Dow Jones index

    When was Journey Medical Corporation's last earnings report?

    Journey Medical Corporation's most recent earnings report was on May 14, 2025

    When does Journey Medical Corporation report earnings?

    The next expected earnings date for Journey Medical Corporation is August 12, 2025
    On this page